Delivery Order SPE2DB22D2206-SPE2DB23FJM55
Award Date 7/31/23
Potential Completion Date 8/21/23
Potential Value $7.5K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $7,488.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 mg IBRANCE tablets. Under this order, Amerisourcebergen will deliver 7 boxes of the cancer treatment drug to a facility in Conshohocken, Pennsylvania by October 19th to support the DLA's medical supply chain operations. As a top pharmaceutical distributor, Amerisourcebergen routinely fulfills delivery orders under the DLA's Prime Vendor contracts to provide...
- The Defense Logistics Agency awarded a $7,484.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 125 mg tablets of IBRANCE, an oncology medication. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by September 19, 2023 in support of DLA's medical supply chain responsibilities. As a top 10 contractor supporting the DLA's pharmaceutical distribution programs, Amerisourcebergen will deliver the cancer treatment to military treatment...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $15,000 to Amerisourcebergen Drug Corporation. The order is for 21 capsules of the pharmaceutical IBRANCE, which will be delivered to a facility in Conshohocken, Pennsylvania by August 21, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor. No major subcontractors or set aside designations were indicated. The Defense...
- The Defense Logistics Agency awarded a $15,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 21 capsules of the pharmaceutical IBRANCE 125 MG. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by September 20, 2023 in support of the Agency's medical supply needs. As a major pharmaceutical distributor, Amerisourcebergen will deliver the cancer treatment to DLA from its corporate headquarters and distribution division located in...
- The Defense Logistics Agency awarded a $7,488.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the purchase of 4561755531 IBRANCE 100 MG TABLET 7S. The place of performance is Conshohocken, Pennsylvania. The order period of performance is from August 9, 2023 through August 30, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill the order requirements without the use of major subcontractors. The Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ibrance 125 mg tablets (7-count) under a firm fixed-price contract with a ceiling value of $8,555.21. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by January 23, 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $7,490.17 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 21 capsules of the pharmaceutical IBRANCE 75 MG. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order period of performance is September 6 through September 27, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this delivery order supports DLA's mission to provide critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,236.16 to AmerisourceBergen Drug Corp for the supply of Ibrance 125 mg tablets (7-count units) on August 25, 2025, with completion scheduled for September 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $24,367.44 to AmerisourceBergen Drug Corp for the supply of Ibrance 100 mg capsules (21-count package) on August 27, 2025, with an ultimate completion date of September 18, 2025. This competitive award uses firm fixed pricing and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in that...
- The Defense Logistics Agency awarded a $29,955.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 21 capsules of the pharmaceutical IBRANCE (palbociclib) 100 mg. The order is being fulfilled from Amerisourcebergen's Conshohocken, Pennsylvania facility to support the Defense Logistics Agency's logistics and procurement programs. As a top pharmaceutical distributor, Amerisourcebergen will deliver the cancer medication to DLA without use of subcontractors. The delivery...